---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-005068"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2023-02-28T23:59:59+00:00"
generated_at: "2026-06-18T22:33:00.297873+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GoodRx Q4 revenue $184.1M beats guidance; Adjusted EBITDA margin 26.9% exceeds expectations

## Summary
- Q4 revenue $184.1M, above guidance; net loss $2.01M (includes $29.4M stock-based comp).
- Adjusted EBITDA $49.6M (26.9% margin), exceeding guidance; Adjusted Net Income $27.4M (14.9% margin).
- Full year 2022 revenue $766.6M; Adjusted EBITDA $213.5M (27.8% margin).
- Subscription offerings grew 42% YoY; over 7M consumers of prescription-related offerings.
- Co-CEO cites strong subscription growth and efficiency improvements; 900K prescribers active.

## SEC filing metadata
- accession: 0000950170-23-005068
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2023-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000095017023005068/0000950170-23-005068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000095017023005068/gdrx-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-005068
- JSON: https://secwatch.observer/filing/0000950170-23-005068.json
- Plain text: https://secwatch.observer/filing/0000950170-23-005068.txt

## Key facts
- Earnings Releases
  GoodRx Holdings, Inc. reported Full Year 2022 results: revenue $766.6 million, net income $32.8 1 million.
  - Period: Full Year 2022
  - Revenue: $766.6 million
  - Net income: $32.8 1 million
  - Result: reported results
  source text: Full Year 2022 Highlights • Total revenue of $766.6 million • Net loss of $32.8 1 million; Net loss margin of 4.3%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000095017023005068/0000950170-23-005068-index.htm
- Earnings Releases
  GoodRx Holdings, Inc. reported Fourth Quarter 2022 results: revenue $184.1 million, net income $2.0 1 million.
  - Period: Fourth Quarter 2022
  - Revenue: $184.1 million
  - Net income: $2.0 1 million
  - Result: reported results
  source text: Fourth Quarter 2022 Highlights • Total revenue of $184.1 million, exceeding previously announced guidance • Net loss of $2.0 1 million; Net loss margin of 1.1%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000095017023005068/0000950170-23-005068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.